GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Radiotherapy as Immunotherapy of Tumors

$437,914
Samuel Strober · Stanford University · R01 · FY2015 · CA

Radiotherapy as Immunotherapy of Tumors

$437,914
Samuel Strober · Stanford University · R01 · FY2016 · CA

Radiotherapy as Immunotherapy of Tumors

$437,914
Samuel Strober · Stanford University · R01 · FY2012 · CA

Glutamine synthetase in cancer cell metabolism and oncogenesis

$437,819
Wei-Xing Zong · Rutgers, The State Univ Of N.J. · R01 · FY2019 · CA

Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas

$437,758
Peter J Allen · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA

Targeting HMGA1 Tumor-Stromal Networks in Pancreatic Carcinogenesis

$437,746
Linda M S Resar · Johns Hopkins University · R01 · FY2025 · CA

Magnetoresistive Sensor Platform for Parallel Cancer Marker Detection

$437,727
Marc D Porter · University Of Utah · U01 · FY2011 · CA

Targeting MUC1-induced Tumor-stromal Metabolic Cross-talk in Pancreatic Cancer

$437,718
Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2016 · CA

Multi-modal129 Xe Probes for Tumor Detection

$437,718
Ivan Julian Dmochowski · University Of Pennsylvania · R33 · FY2009 · CA

Surgical and Animal Core

$437,672
Dai Fukumura · Massachusetts General Hospital · P01 · FY2012 · CA

Ras-mediated signals in human epithelial cell transformation and metastasis

$437,665
Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia

$437,443
Oleh Taratula · Oregon State University · R37 · FY2023 · CA

U-01 CONSORTIUM FOR THE STUDY OF CHRONIC PANCREATITIS,DIABETES AND PANCREATIC CANCER CLINICAL CENTERS

$437,436
Christopher E Forsmark · University Of Florida · U01 · FY2024 · DK

Studying the role of eIF4A in Pancreatic Cancer

$437,264
Christine Iok In Chio · Columbia University Health Sciences · R01 · FY2023 · CA

Multifunctional nanoparticles for combinational therapy of pancreatic cancer

$437,210
Juan Luis Vivero-Escoto · University Of North Carolina Charlotte · R15 · FY2015 · CA

Role of MFG-E8 in Tumor Biology and Immunophysiology

$437,190
Mark Udey · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Molecular Basis of Antidiabetogenic Hormone Action

$437,160
George G Holz · Upstate Medical University · R01 · FY2016 · DK

Molecular Basis of Antidiabetogenic Hormone Action

$437,160
George G Holz · Upstate Medical University · R01 · FY2017 · DK

Engagement Optimization

$437,124
Cindy Kay Blair · University Of New Mexico Health Scis Ctr · U2C · FY2025 · CA

MEK AND PI3K INHIBITION IN THE REGULATION OF PANCREATIC CANCER METABOLISM

$437,090
Lewis C Cantley · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA

Mitochondrial heterogeneity as the origin of chemoresistance in pancreatic cancer

$437,031
Andrea Viale · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA

Clinical Studies of Circulating Epithelial Cancer Cells

$436,830
Paul O. P. Ts'o · Ccc Diagnostics, Llc · R44 · FY2006 · CA

MUC1 AND RESISTANCE OF CANCER CELLS TO ONCOLYTIC VIROTHERAPY

$436,701
Valery Zurabovich Grdzelishvili · University Of North Carolina Charlotte · R15 · FY2012 · CA

Molecular mechanisms of Hedgehog receptor function

$436,635
Philip A Beachy · Stanford University · R01 · FY2018 · GM

Surgical and Animal Core

$436,627
Dai Fukumura · Massachusetts General Hospital · P01 · FY2016 · CA